Ligand Pharmaceuticals Inc (LGND)
116.89
+5.33
(+4.78%)
USD |
NASDAQ |
Nov 21, 16:00
116.89
0.00 (0.00%)
After-Hours: 17:47
Ligand Pharmaceuticals Price: 116.89 for Nov. 21, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 20, 2024 | 111.59 | 112.00 | 109.52 | 111.56 | 133450.0 |
| Nov 19, 2024 | 110.72 | 112.26 | 109.78 | 111.80 | 98184.00 |
| Nov 18, 2024 | 110.87 | 113.04 | 109.44 | 111.67 | 125916.0 |
| Nov 15, 2024 | 116.52 | 116.52 | 110.32 | 111.71 | 107763.0 |
| Nov 14, 2024 | 123.22 | 125.76 | 114.39 | 115.45 | 135153.0 |
| Nov 13, 2024 | 122.00 | 123.72 | 120.99 | 122.08 | 219090.0 |
| Nov 12, 2024 | 123.08 | 124.46 | 119.68 | 120.74 | 120763.0 |
| Nov 11, 2024 | 122.24 | 124.19 | 120.83 | 123.47 | 209239.0 |
| Nov 08, 2024 | 126.27 | 127.26 | 116.96 | 121.25 | 260623.0 |
| Nov 07, 2024 | 118.33 | 129.90 | 115.16 | 129.90 | 271767.0 |
| Nov 06, 2024 | 114.09 | 116.95 | 111.72 | 116.90 | 214603.0 |
| Nov 05, 2024 | 109.57 | 111.58 | 108.31 | 111.13 | 86390.00 |
| Nov 04, 2024 | 109.14 | 110.63 | 108.11 | 110.22 | 99797.00 |
| Nov 01, 2024 | 107.05 | 110.79 | 107.05 | 110.04 | 121354.0 |
| Oct 31, 2024 | 109.56 | 109.56 | 105.48 | 105.70 | 100359.0 |
| Oct 30, 2024 | 114.93 | 115.10 | 109.81 | 109.81 | 63907.00 |
| Oct 29, 2024 | 112.98 | 115.53 | 112.98 | 115.53 | 118744.0 |
| Oct 28, 2024 | 113.26 | 113.51 | 110.00 | 113.38 | 206902.0 |
| Oct 25, 2024 | 111.19 | 113.37 | 111.13 | 111.82 | 122752.0 |
| Oct 24, 2024 | 106.89 | 111.04 | 106.32 | 110.99 | 145077.0 |
| Oct 23, 2024 | 106.29 | 107.28 | 104.58 | 106.89 | 64218.00 |
| Oct 22, 2024 | 106.19 | 106.51 | 104.29 | 106.50 | 68775.00 |
| Oct 21, 2024 | 106.83 | 109.41 | 106.55 | 106.78 | 120614.0 |
| Oct 18, 2024 | 106.08 | 106.57 | 104.25 | 106.39 | 53604.00 |
| Oct 17, 2024 | 107.50 | 108.19 | 105.16 | 105.89 | 72961.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
40.89
Minimum
Mar 16 2020
139.27
Maximum
Feb 09 2021
74.61
Average
71.75
Median
Jun 17 2020
Price Benchmarks
| Regeneron Pharmaceuticals Inc | 744.42 |
| Agios Pharmaceuticals Inc | 55.55 |
| ADMA Biologics Inc | 21.30 |
| Pieris Pharmaceuticals Inc | 15.93 |
| AnaptysBio Inc | 21.18 |
Price Related Metrics
| PE Ratio | 46.57 |
| PS Ratio | 13.85 |
| PEG Ratio | 0.2301 |
| Price to Book Value | 2.626 |
| Price to Free Cash Flow | 302.98 |
| Earnings Yield | 2.15% |
| Market Cap | 2.209B |
| PEGY Ratio | 0.2301 |
| Operating PE Ratio | 117.44 |